9.3K
Downloads
194
Episodes
From Wall Street’s opening bell to market close.
Episodes
![Bell2Bell Podcast featuring Amir Adnani, President & CEO of Uranium Energy Corp. [Video Edition]](https://pbcdn1.podbean.com/imglogo/image-logo/10151097/Bell2Bell-PodcastCover_300x300.jpg){kind=logo}
Tuesday Mar 30, 2021
Tuesday Mar 30, 2021
Bell2Bell’s latest podcast features the return of Amir Adnani, President and CEO of Uranium Energy Corp (NYSE American: UEC), a U.S.-based uranium mining and exploration company. Under his guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation. The company has since developed an extensive pipeline of low-cost, near-term production projects and recently put into place a physical uranium holding initiative.
During the interview, Adnani provided an update on Uranium Energy’s recent news and milestones since his last appearance on The Bell2Bell Podcast, in early February.
Tuesday Mar 30, 2021
Tuesday Mar 30, 2021
Bell2Bell’s latest podcast features the return of Amir Adnani, President and CEO of Uranium Energy Corp (NYSE American: UEC), a U.S.-based uranium mining and exploration company. Under his guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation. The company has since developed an extensive pipeline of low-cost, near-term production projects and recently put into place a physical uranium holding initiative.
During the interview, Adnani provided an update on Uranium Energy’s recent news and milestones since his last appearance on The Bell2Bell Podcast, in early February.
Monday Mar 29, 2021
Monday Mar 29, 2021
Bell2Bell’s latest podcast features United Medical Equipment Business Solutions Network Inc. President Jason Pratt and VP of Sales Brian Gartland. In the interview, they explain United Medical Equipment (UME)’s trusted-provider business model.
“Every day 10,000 people turn 65 in the United States. Having a home health background, I saw the need to have trusted resources for seniors and their families,” Pratt said.
Monday Mar 29, 2021
Monday Mar 29, 2021
Bell2Bell’s latest podcast features United Medical Equipment Business Solutions Network Inc. President Jason Pratt and VP of Sales Brian Gartland. In the interview, they explain United Medical Equipment (UME)’s trusted-provider business model.
“Every day 10,000 people turn 65 in the United States. Having a home health background, I saw the need to have trusted resources for seniors and their families,” Pratt said.
Friday Mar 12, 2021
Friday Mar 12, 2021
Bell2Bell’s latest podcast features Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).
As discussed in the podcast, XPhyto Therapeutics recently received ISO certification for its rapid point-of-care COVID-19 PCR diagnostic test.
“We expect to be in the market very soon, within 30 days, pending European approval right now,” Rogers said. “Testing is highly relevant and will be for many years to come. The virus is endemic. It appears that it will be a forever problem. It will be active at all times for the foreseeable future somewhere in the world, and testing is a major part of managing that situation. The rollout of vaccines will not be uniform across the globe. There will be significant discrepancies, primarily for logistical and economic reasons, between the developing world and the developed world. Any time there’s international travel, and in particular between jurisdictions with disparity of economic comfort or success, there’s going to be this need for ongoing testing.”
Friday Mar 12, 2021
Friday Mar 12, 2021
Bell2Bell’s latest podcast features Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).
As discussed in the podcast, XPhyto Therapeutics recently received ISO certification for its rapid point-of-care COVID-19 PCR diagnostic test.
“We expect to be in the market very soon, within 30 days, pending European approval right now,” Rogers said. “Testing is highly relevant and will be for many years to come. The virus is endemic. It appears that it will be a forever problem. It will be active at all times for the foreseeable future somewhere in the world, and testing is a major part of managing that situation. The rollout of vaccines will not be uniform across the globe. There will be significant discrepancies, primarily for logistical and economic reasons, between the developing world and the developed world. Any time there’s international travel, and in particular between jurisdictions with disparity of economic comfort or success, there’s going to be this need for ongoing testing.”
Wednesday Feb 17, 2021
Wednesday Feb 17, 2021
Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist International Corp. (OTCQB: CNSC). As noted in the interview, CannAssist International is a company born on research.
“We really saw a lot of stuff coming out in the industry early on where the application of CBD was very good and very promising, however, the reality of how things were being presented didn’t translate that level of performance,” Palumbo said. “Our initial attempts were at enhancing the performance of the CBD molecule… the research focused on making sure that we could make this product and we could make it in large volume. Once the concept was proven, which we did through third-party labs, we could show what properties it had to enhance… the problems that the CBD was having. One was, because of its oil solubility, its bioavailability was limited. The other one… was stability… We ran an analysis to show we could enhance that quite a bit, and we’ve got a shelf life now of two years.”
Palumbo then spoke to CannAssist’s business model, including the decision to take the company public on the OTCQB Venture Market.
Wednesday Feb 17, 2021
Wednesday Feb 17, 2021
Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist International Corp. (OTCQB: CNSC). As noted in the interview, CannAssist International is a company born on research.
“We really saw a lot of stuff coming out in the industry early on where the application of CBD was very good and very promising, however, the reality of how things were being presented didn’t translate that level of performance,” Palumbo said. “Our initial attempts were at enhancing the performance of the CBD molecule… the research focused on making sure that we could make this product and we could make it in large volume. Once the concept was proven, which we did through third-party labs, we could show what properties it had to enhance… the problems that the CBD was having. One was, because of its oil solubility, its bioavailability was limited. The other one… was stability… We ran an analysis to show we could enhance that quite a bit, and we’ve got a shelf life now of two years.”
Palumbo then spoke to CannAssist’s business model, including the decision to take the company public on the OTCQB Venture Market.
Wednesday Feb 10, 2021
Wednesday Feb 10, 2021
Bell2Bell’s latest podcast features Amir Adnani, President and CEO of Uranium Energy Corp. (NYSE American: UEC), a U.S.-based uranium mining and exploration company. Under his guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation. The company has since developed an extensive pipeline of low-cost, near-term production projects.
During the interview, Adnani delivered an overview of Uranium Energy’s business model before providing an in-depth examination of some recent company news that is expected to play a key role in its operations throughout the coming year.
Wednesday Feb 10, 2021
Wednesday Feb 10, 2021
Bell2Bell’s latest podcast features Amir Adnani, President and CEO of Uranium Energy Corp. (NYSE American: UEC), a U.S.-based uranium mining and exploration company. Under his guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation. The company has since developed an extensive pipeline of low-cost, near-term production projects.
During the interview, Adnani delivered an overview of Uranium Energy’s business model before providing an in-depth examination of some recent company news that is expected to play a key role in its operations throughout the coming year.